Education
About Us
Working with TipRanks
Follow Us
TriSalus Life Sciences (TLSI)
NASDAQ:TLSI
Earnings Data
Report Date
Nov 18, 2025Before Open (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.15Last Year’s EPS
-0.12Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook with significant revenue growth, successful product launches, and strategic capital raises. However, there were challenges with gross margin decline, increased administrative expenses, and a delay in achieving EBITDA positivity. Overall, the positive aspects of growth and expansion outweigh the financial setbacks.Company Guidance
Strong Revenue Growth
TriSalus Life Sciences reported $11.2 million in net sales for Q2 2025, marking a 52% increase compared to Q2 2024 and a 22% sequential gain over Q1 2025.
Launch of TriNav FLX Infusion System
The company successfully launched the TriNav FLX infusion system, which has demonstrated improved trackability and is engineered for use in tortuous vascular anatomy.
Expansion of Product Portfolio
TriSalus expanded its product suite with the launch of TriNav LD and TriGuide for larger vessels, and the full commercial launch of TriNav FLX.
Successful Capital Raise
TriSalus completed a $22 million private placement with healthcare-focused institutional investors, strengthening its balance sheet.
Increased Unique Ordering Accounts
The number of unique ordering accounts increased by 28% year-over-year.
New Reimbursement Code for TriNav
Centers for Medicare and Medicaid Services issued code C8004, providing coverage for simulation or mapping procedures using TriNav.
Reduction in Operating Losses
Operating losses for Q2 2025 were reduced to $7.3 million from $8.2 million in Q2 2024.
TLSI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TLSI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 12, 2025 | $3.65 | $3.95 | +8.22% |
May 15, 2025 | $4.90 | $5.11 | +4.29% |
Mar 27, 2025 | $5.58 | $5.50 | -1.43% |
Nov 14, 2024 | $4.50 | $4.01 | -10.89% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does TriSalus Life Sciences (TLSI) report earnings?
TriSalus Life Sciences (TLSI) is schdueled to report earning on Nov 18, 2025, Before Open (Confirmed).
What is TriSalus Life Sciences (TLSI) earnings time?
TriSalus Life Sciences (TLSI) earnings time is at Nov 18, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TLSI EPS forecast?
TLSI EPS forecast for the fiscal quarter 2025 (Q3) is -0.15.